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Abstract
Food availability regulates basal metabolism and progression of many diseases, and liver plays an important role in these
processes. The effects of food availability on digital gene expression profile, physiological and pathological functions in liver
are yet to be further elucidated. In this study, we applied high-throughput sequencing technology to detect digital gene
expression profile of mouse liver in fed, fasted and refed states. Totally 12162 genes were detected, and 2305 genes were
significantly regulated by food availability. Biological process and pathway analysis showed that fasting mainly affected lipid
and carboxylic acid metabolic processes in liver. Moreover, the genes regulated by fasting and refeeding in liver were mainly
enriched in lipid metabolic process or fatty acid metabolism. Network analysis demonstrated that fasting mainly regulated
Drug Metabolism, Small Molecule Biochemistry and Endocrine System Development and Function, and the networks
including Lipid Metabolism, Small Molecule Biochemistry and Gene Expression were affected by refeeding. In addition,
FunDo analysis showed that liver cancer and diabetes mellitus were most likely to be affected by food availability. This study
provides the digital gene expression profile of mouse liver regulated by food availability, and demonstrates the main
biological processes, pathways, gene networks and potential hepatic diseases regulated by fasting and refeeding. These
results show that food availability mainly regulates hepatic lipid metabolism and is highly correlated with liver-related
diseases including liver cancer and diabetes.
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Introduction
As the source of materials for basal metabolism, food availability
plays an important role in the progression of diseases [1]. There
are numerous reports on undernutrition in humans. For example,
the classic Minnesota experiment assessed the physiological and
psychological effects of severe food restriction and rehabilitation
[2], and Dutch and Chinese data showed that prenatal exposure to
famine increases risk of schizophrenia in later life [3,4].
Throughout the 20th century, interest in food availability and
human health changed from concerns on the physiology of
undernutrition to increasing health problems associated with
overnutrition [5]. Overnutrition-related chronic diseases, includ-
ing cardiovascular diseases, obesity and diabetes, are becoming
increasingly common in the world as a main result of changes in
diet and physical activity [1,6]. It was reported that an estimated
14% of US adults used fasting as a means to control body weight
and this approach has long been advocated as an intermittent
treatment for gross refractory obesity [7]. Meanwhile, calorie
restriction and alternate-day fasting were reported to induce
weight loss, extend lifespan and prevent the common chronic
diseases in various species [8,9,10]. Food availability shows
multiple physiological and pathological effects, therefore the
molecular mechanisms associated with fasting and refeeding needs
to be understood in depth.
Being the biggest endocrine gland in our body, liver has a
central role in metabolism and plays a key role in the maintenance
of nutrient homeostasis [11]. Many of the regulatory effects in
response to diet initially occur in liver, which then modulates the
activities of other organs in terms of nutrient utilization and
metabolism [12]. Thus, the consequences of food availability in
liver are wide spread. Fasting induces many changes especially
lipid and glucose metabolism in liver, key among these changes are
fatty acid oxidation and hepatic gluconeogenesis [13,14]. The
previous studies show that fasting induces peroxisome proliferator-
activated receptor-a (PPARa), which stimulates the expression of
the acyl-CoA dehydrogenases (ACDs) and other fatty acid
oxidation genes [15,16]. While, phosphoenolpyruvate carboxyki-
nase (PEPCK), a key enzyme in hepatic gluconeogenesis, is
induced by glucagon, catecholamines and glucocorticoids during
periods of fasting, but is dominantly inhibited by glucose-induced
increases in insulin secretion upon refeeding [17]. Some other
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altered by nutritional status and considered as drug targets for
diabetes and obesity [18,19]. The way to alter the key genes to
keep metabolism homeostasis becomes popular in the treatment of
chronic diseases. Therefore, the global gene profiling of liver under
different nutritional status will be very helpful to elucidate the key
genes and the gene networks regulated by food availability.
Microarray technology has been applied to study the genome-
wide gene expression levels in mammalian tissues regulated by food
availability [20]. Microarray expression analysis has been success-
fully used in the genomic profiling of short- and long-term caloric
restrictioneffectsinthe liverofagingmice[21].Similarly,starvation
response in mouse liver showed strong correlation with life-span-
prolonging processes induced by calorie restriction [22]. In chicken
liver, microarray experiments revealed the central role of lipid and
acetyl-CoA metabolisms and its regulation at transcriptional level in
response to short-term fasting [23]. Recently, high-throughput
sequencing is emerging as an attractive alternative to microarrays
for transcriptome profiling, because high-throughput sequencing-
based expression analysis shows major advances in robustness,
resolution and reproducibility based on its relatively unbiased and
direct digital readout [24,25,26]. In terms of both profiling coverage
and quantitative accuracy of high throughput sequencing, the
application of this new technology in transcriptome profiling altered
by nutrient status is important to further understand the underlying
mechanisms.
In this study, we measured the gene expression profile in
feeding, fasting and refeeding mouse liver by high-throughput
sequencing, and showed the main biological processes, pathways,
networks and potential liver related diseases regulated by food
availability.
Results
High throughput sequencing and the top abundant,
abundance change and fold change genes in mouse liver
regulated by food availability
To global survey the gene expressing pattern in mouse liver
regulated by food availability, high throughput sequencing was
applied in this study. Finally, we obtained about 10.48, 10.45 and
9.72 million reads of high quality clean tags from mice fed ad
libitum, fasted and refed respectively (Figure 1A). In these high
quality clean tags, averagely, 81.6%, 65.8% and 38.6% reads can
be mapped to annotated mouse genome, genes, and unique genes
respectively (Figure 1B). Totally 12162 genes were detected, and
10878, 10702 and 10708 unique genes were detected and
quantified from fed, fasted and refed samples respectively, which
shared 9475 genes in common (Figure 1C).
Based on the Solexa sequencing data, the top 30 highly
expressed genes in normal feeding adult mouse liver were shown in
Figure 1D. Apoa1 gene encoding Apolipoprotein A-I, a major
protein component of high density lipoprotein, was identified as
the most abundant gene using this method. Furthermore, the top
15 abundance changes of genes upregulated by fasting were shown
in Figure 1E. Interestingly, the abundance changes of these 15
genes upregulated by fasting were almost completely reversed by
refeeding except Apoa4 (Figure 1E). Even in the top 100
abundance changes of genes upregulated by fasting, 82 genes
were almost completely reversed by refeeding. The top 15
abundance changes of genes downregulated by fasting were
shown in Figure 1F. However the abundance changes of Mup3,
Fgg, Alb, B2m and Fgb induced by fasting were not well reversed by
refeeding (Figure 1F). In addition, we showed the top 15 fold
changes of genes upregulated or downregulated by fasting in
Figure 1G,H. 13 of the top 15 fold change genes upregulated by
fasting were still upregulated after refeeding, however 12 of the top
15 fold change genes downregulated by fasting will be upregulated
by refeeding compared to normal feeding. The above results show
that the upregulated or downregulated genes in top abundance or
fold change have different interesting dynamic pattern and might
have critical functions in adaption to food availability.
To understand the final effects of refeeding on gene expression,
the top 15 abundance or fold change genes upregulated or
downregulated by refeeding compared to normal feeding were
shown in Figure S2A,B.
Differentially expressed genes and clustering
Among the 10878, 10702 and 10708 unique genes detected
from fed, fasted and refed samples, differentially expressed genes
between these three states were quantified and shown in Figure
S3A. To avoid the possible noise signal from high-throughput
sequencing, the genes with average TPM (transcripts per million)
less than 1 in these three states were excluded. The remained 8815
genes and their abundance were shown in Table S2, and were
used to calculate the fold changes and false discovery rate (FDR).
In this study, the absolute fold change no less than 1.5 and FDR
less than 0.001 were used to define the differentially expressed
genes. According to this definition, totally 2305 genes were
differentially expressed between fed, fasted and refed states (Figure
S3A). There were 1509 and 1180 genes significantly affected by
fasting and refeeding respectively compared to normal feeding,
and 384 genes regulated by fasting were not well reversed by
refeeding (Figure S3B).
To gain insights into the 2305 differentially expressed genes
regulated by food availability, we divided them into 8 clusters
based on the different dynamic pattern induced by fasting and
refeeding (Figure S3C). Cluster 1 to 3 contained the genes
upregulated by fasting, which is named as Cluster A. Cluster 4 to 6
contained genes downregulated by fasting, which is named as
Cluster B. Cluster 7 and 8 included the genes unaffected by fasting
but regulated by refeeding.
The main biological processes and pathways regulated
by fasting and refeeding
To identify the possible biologic functions regulated by fasting,
the 8815 genes were divided into Cluster A, B and C with 472
genes upregulated, 1037 genes downregulated and 7306 genes
unaffected by fasting respectively (Figure 2A). Based on Gene
Ontology analysis, Cluster A genes mainly enriched in carboxylic
acid metabolic process, especially in its sub-process monocarbox-
ylic acid or even more specifically in fatty acid metabolic process
(Figure 2B). Cluster A genes also enriched in generation of
precursor metabolites and energy, especially in its sub-process
electron transport. Cluster B genes mainly enriched in lipid
metabolic process, especially in its sub-process steroid metabolic
process typically including steroid and sterol biosynthetic processes
(Figure 2B). Fasting-affected 1509 genes including Cluster A and
Cluster B mainly enriched in lipid and carboxylic acid metabolic
processes, generation of precursor of metabolites and energy
(Figure 2B). Cellular lipid metabolic process and steroid
biosynthetic process in lipid metabolic process were also enriched.
These results show that fasting mainly affect lipid and carboxylic
acid metabolic processes in liver, but will not affect some hepatic
basic biological processes including biopolymer, nucleic acid and
macromolecule metabolic processes.
Furthermore, Ingenuity and KEGG pathway analysis were
performed to further elucidate the biological functions of the gene
clusters regulated by fasting. The top 5 Ingenuity and KEGG
Food-Affected Hepatic Gene Expression Profile
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27553Figure 1. Sequencing and mapping messages of mouse liver mRNA profiling under feeding, fasting and refeeding conditions.
(A) Reads of high quality clean tags from high-throughput sequencing experiments. Total liver RNA from C57BL/6 mice fed ad libitum with chow,
fasted for 24 hr, or fasted for 24 hr and refed for 24 hr was used to prepare the high-throughput sequencing library. (B) Proportions of high quality
clean tags unmapped and/or mapped to unique genes, multiple genes and genome. (C) Gene numbers between feeding, fasting and refeeding
states. (D) The top 30 abundant genes in normal feeding mouse liver from the high-throughput sequencing were quantified and shown as transcripts
per million (TPM). (E) The top 15 abundance change of genes upregulated by fasting, and their abundance change following refeeding. N, gene
abundance under normal feeding condition; F, gene abundance under fasting condition; R, gene abundance under refeeding condition. (F) The top
15 abundance changes of genes downregulated by fasting, and their abundance change following refeeding. (G) The top 15 fold change of genes
upregulated by fasting, and their fold change following refeeding. (H) The top 15 fold change of genes downregulated by fasting, and their fold
change following refeeding.
doi:10.1371/journal.pone.0027553.g001
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with associated genes. These pathway analysis data further
confirmed that lipid and carboxylic acid metabolic processes in
liver, especially fatty acid metabolism, were the main biological
processes regulated by fasting.
To identify the possible biologic functions regulated by both the
whole fasting and refeeding process, the 8815 genes were divided
into nine clusters according to the dynamic patterns upregulated,
downregulated or unaffected by fasting or refeeding as shown in
Figure 3A,C. Among the fasting-affected 1509 genes, fasting-
upregulated 472 genes were divided into Cluster 1, 2, 3, and
fasting-downregulated 1037 genes were divided into Cluster 4, 5,
6, according to their expression upregulated, downregulated or
unaffected by refeeding. 384 genes in Cluster 1, 2, 4 and 5 were
significantly regulated by fasting, and none of them recovered to
normal feeding levels after refeeding (Figure 3A). Interestingly,
Cluster 1 genes are enriched in ion and chemical homeostasis and
homeostatic process (Figure 3B); Cluster 2 genes are mainly
enriched in carboxylic acid metabolic process, especially in its sub-
process monocarboxylic acid metabolic process including amino
acid metabolic process; Cluster 4 genes are enriched in alcohol
and sterol metabolic processes and steroid biosynthetic process,
especially in sterol or more specifically in cholesterol biosynthetic
process; Cluster 5 genes are enriched in regulation of cell motility
and locomotion. 1125 genes in Cluster 3 and Cluster 6 were
significantly upregulated or downregulated by fasting, but almost
completely recovered to normal feeding levels after refeeding
(Figure 3A,C). Cluster 3 mainly enriched in carboxylic acid
metabolic process and generation of precursor metabolites and
energy, and Cluster 6 genes mainly enriched in immune responses
(Figure 3B,D). These data suggest that immune responses,
carboxylic acid metabolic process and generation of precursor
metabolites and energy are significantly regulated by fasting, but
can be recovered to normal feeding states after refeeding. Fasting-
unaffected 7306 genes were divided into Cluster 7, 8, 9 according
to their expression upregulated, downregulated or unaffected by
refeeding. 796 genes in Cluster 7 and 8 were not directly affected
by fasting, but were upregulated or downregulated respectively
after refeeding (Figure 3C). Cluster 7 genes are enriched in
macromolecule biosynthetic process, protein metabolic process
and macromolecule catabolic process (Figure 3D), and Cluster 8
genes are enriched in amino acid, amine and nitrogen compound
catabolic processes. These data demonstrate the genes regulated
by fasting or refeeding with similar dynamic pattern are usually
enriched in similar feature biological processes affected by food
availability. Furthermore, all the differentially expressed genes are
mainly enriched in carboxylic acid and lipid metabolic processes
and generation of precursor metabolites and energy (Figure 3).
Moreover, Ingenuity and KEGG pathway analysis showed that
the different gene clusters with different dynamic patterns
regulated by fasting and refeeding usually enriched in different
pathways, and all the differentially expressed genes are mainly
enriched in the pathways of fatty acid metabolism and metabolism
of xenobiotics by cytochrome P450 (Table S1).
The main networks regulated by fasting and refeeding
To further understand the global gene changes during fasting-
refeeding process, we sought to computationally decipher the
principle networks regulated by fasting and refeeding using
Ingenuity. The top 5 gene networks regulated by fasting were
combined and shown in Figure 4A, including Drug Metabolism,
Small Molecule Biochemistry, Endocrine System Development
and Function (Figure 4C), Lipid Metabolism, Small Molecule
Biochemistry, Molecular Transport (Figure 4D), and Lipid
Metabolism, Molecular Transport, Small Molecule Biochemistry
(Figure 4E). The top 5 gene networks significantly regulated by
refeeding compared to normal feeding were shown in Figure 4B,
including Lipid Metabolism, Small Molecule Biochemistry, Gene
Expression (Figure 4F), Lipid Metabolism, Small Molecule
Biochemistry and Molecular Transport (Figure 4G), Hepatic
System Disease, Lipid Metabolism and Molecular Transport
(Figure 4H). The network analysis demonstrates that Lipid
Metabolism, Small Molecule Biochemistry and Molecular Trans-
port are the three main sub-networks regulated by fasting and
refeeding. In addition, the sub-network Hepatic System Disease
regulated by refeeding implicates that fasting and refeeding can
significantly affect the development of hepatic diseases.
Figure 2. Genes and the related biological processes in mouse
liver regulated by fasting. (A) The 8815 selected genes as described
in Materials and Methods and Figure S3A were separated into three
distinct clusters according to the genes upregulated, downregulated, or
unaffected by fasting compared with normal feeding. Red lines indicate
Cluster A including 472 genes upregulated by fasting. Green lines
indicate Cluster B including 1037 genes downregulated by fasting.
Purple lines indicate 1509 genes affected by fasting, which include all
genes in Cluster A and B. Yellow lines indicate Cluster C including 7306
genes unaffected by fasting. N, gene abundance under normal feeding
condition; F, gene abundance under fasting condition. (B) The clustered
genes were assigned to different biological processes based on Gene
Ontology using the web tool DAVID. The top 5 biological functions and
the case genes in each cluster ranked by P-value were listed (P,0.001,
case genes $10).
doi:10.1371/journal.pone.0027553.g002
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refeeding
To further elucidate the correlation between food availability
and hepatic diseases, we assigned the hepatic genes regulated by
fasting and refeeding to different diseases using web tool FunDO.
As shown in Figure 5A,B, 1509 genes regulated by fasting were
mainly related with diabetes mellitus, liver cancer, infection and
liver tumor. Fasting-affected genes enriched in the indicated
diseases were listed in Table S3. In addition, the 1180 genes
significantly affected by refeeding compared to normal feeding
Table 1. The top 5 Ingenuity and KEGG pathways and the associated genes significantly affected by fasting.
Ingenuity Pathway KEGG Pathway
Cluster A
472 genes
Fatty Acid Metabolism Fatty acid metabolism
ACAD11-ACADL-ACADM-ACADVL-ACAT1-ACOX1-ACSL1-ALDH3A2-CPT2-
CPT1A-CYP2E1-DCI-ECH1-EHHADH-HSD17B4-HSD17B10-PECI-SDS-
SLC27A1-SLC27A2
P=6.24E-10
CPT2-TEKT3-ACSL1-ACADL-RGL3-ACADM-ACADVL-ACOX1-CUEDC2-
ALDH3A2-CPT1A-KCNK4-CACNG8-DCI-HSD17B10-HSD17B4-PECI-EHHADH-
OLFR916-ACAT1-CYP4A14
P=1.45E-11
Valine, Leucine and Isoleucine Degradation PPAR signaling pathway
ACAD11-ACADL-ACADM-ACADVL-ACAT1-ALDH3A2-ECH1-EHHADH-
HMGCL-HSD17B4-HSD17B10-SDS
P=6.78E-07
CPT2-TEKT3-ACSL1-PCK1-IFNE-SLC27A2-ANGPTL4-ACADL-RGL3-ACADM-
ACOX1-CUEDC2-APOA1-FABP7-CPT1A-KCNK4-CACNG8-CYP7A1-ZSCAN10-
CYP8B1-PPARA-ZFP831-SLC27A1-APOA5-EHHADH-OLFR916-CYP4A14
P=5.69E-10
LPS/IL-1 Mediated Inhibition of RXR Function Linoleic acid metabolism
ABCC2-ABCC3-ACOX1-ACSL1-ALDH3A2-APOC4-CPT2-CPT1A-CYP7A1-
FMO1-GSTT2-JUN-LBP-NR1I2-NR1I3-PAPSS2-PPARA-SLC27A1-SLC27A2-
SULT1A1
P =1.23E-06
AGXT-AA960436-ABAT-GOT1-PCX-LINGO4-GPT-ASL-ASNS-VWA3B-GPT2
P=6.15E-06
Propanoate Metabolism Alanine and aspartate metabolism
ACAD11-ACADL-ACADM-ACADVL-ACAT1-ACSL1-ALDH3A2-ECH1-
EHHADH-SDS-SUCLG1
P=1.64E-06
CYP2C37-CYP2E1-FCRLA-CYP2C39-CYP3A11-GPR124-CYP3A13-CYP3A16-
ZC3H10-CCR1L1-CYP3A25-PLA2G12A-CYP2C50
P=1.84E-05
b-alanine Metabolism Citrate cycle (TCA cycle)
ACAD11-ACADL-ACADM-ACADVL-ALDH3A2-DPYD-ECH1-EHHADH-SDS
P=5.60E-06
PCK1-IFNE-ACO2-MIS12-FH1-A830018L16RIK-PCX-LINGO4-SLC32A1-SUCLG1-
FAM154A-DLST
P=1.24E-04
Cluster B
1037 genes
Biosynthesis of Steroids Complement and coagulation cascades
CYP26A1-DHCR7-HMGCR-IDI1-LSS-SQLE
P =6.16E-04
C9-HDDC3-FGA-TIFA-FGG-C1QA-FAM114A1-C1QC-C4BP-1110007C09RIK-C6-
1110012L19RIK-CD59A-FAM125A-CFH-TXLNA-F2R-F3-CFB-HC-KNG1-MBL2-
OLFR129-CPB2-F11-C8B-C8A
P=4.75E-07
Endometrial Cancer Signaling Nucleotide sugars metabolism
CASP9-CCND1-CDH1-CTNNB1-GRB2-MAPK6-PIK3R1-PTEN-RRAS2
P=7.37E-04
HSD3B7-AKR1E1-HSD17B12-AKR1C6-GM6897-RDH11-OLFR382-UGDH-GALE-
OLFR1246-UGP2
P=1.01E-06
Colorectal Cancer Metastasis Signaling Biosynthesis of steroids
BAX-CASP9-CCND1-CDH1-CTNNB1-FZD7-GRB2-LRP1-MAPK6-MMP15-
PIK3R1-RELA-RHOC-RHOU-RND3-RRAS2-TGFB1-TNFRSF1A-VEGFB
P=2.60E-03
SC5D-DHCR7-HMGCR-LSS-GPSM1-SQLE-MVD-IDI1
P=1.33E-05
ILK Signaling Glycine, serine and threonine metabolism
CCND1-CTNNB1-DSP-FERMT2-MAPK6-MYL9-PARVA-PIK3R1-PTEN-RELA-
RHOC-RHOU-RND3-TNFRSF1A-VEGFB
P=5.50E-03
ALAS2-CBS-SHROOM1-6720468P15RIK-CHKA-HSD3B7-GAMT-PEMT-AKR1E1-
HSD17B12-AKR1C6-GM6897-TARS-RDH11-OLFR382
P=3.46E-04
IL-8 Signaling Metabolism of xenobiotics by cytochrome P450
BAX-CCND1-CDH1-GNA13-GNAI3-KDR-MAPK6-NOX4-PIK3R1-RELA-
RHOC-RHOU-RND3-RRAS2-VEGFB
P=7.42E-03
CYP2C70-ADH1-ATAD4-CYP1A2-FAM71F1-GSTA3-GSTA4-RASGEF1B-GSTM6-
ADH4-GSTM7-UGT2B1-UGT2A1-CYP2C44-GSTM3
P=3.81E-03
Fasting affected 1509 genes
Fatty Acid Metabolism P=3.48E-12 Fatty acid metabolism P=3.32E-08
PXR/RXR Activation P=3.17E-08 Linoleic acid metabolism P=3.13E-07
LPS/IL-1 Mediated Inhibition of RXR Function P=5.44E-07 Glycine, serine and threonine metabolism P=1.04E-06
Tryptophan Metabolism P=6.22E-07 Metabolism of xenobiotics by cytochrome P450 P=3.54E-06
Metabolism of Xenobiotics by Cytochrome P450 P=2.17E-06 PPAR signaling pathway P=1.01E-05
doi:10.1371/journal.pone.0027553.t001
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hepatitis C (Figure 5C,D). Refeeding-affected genes enriched in
the indicated diseases were listed in Table S4. These results
demonstrate that food availability is significantly correlated with
the development of liver cancer and diabetes mellitus.
Discussion
This study provides the basic gene expression profile data of
feeding, fasting and refeeding mouse liver by high throughput
sequencing, and demonstrates the main biological processes,
pathways, networks and potential liver related diseases affected
by fasting and refeeding. Food availability mainly regulates lipid
metabolism, especially fatty acid metabolism in liver, and is
significantly correlated with some liver related diseases including
liver cancer and diabetes. These results should be very helpful to
further understand the metabolism and diseases in liver regulated
by food availability.
High throughput RNA sequencing greatly increases our ability
to quantitatively detect mRNA level with relatively unbiased
measurements of gene abundance [25,27]. With this technology,
we showed the gene expression data of mouse liver under feeding,
fasting and refeeding conditions in Table S2. The top 30 abundant
genes were shown in Figure 1. According to the mouse array data
collected in BioGPS (http://biogps.gnf.org) [28], 24 genes of the
top 30 abundant genes are specifically or most highly expressed in
liver. The rest 6 genes, including B2m, Chchd10, Hint1, Phyh,
Mettl7a1 and Pah are also highly expressed in liver when analyzed
by BioGPS. These results show that our data are comparable with
the previous array data. A common feature of liver is the key
metabolic center. By Gene Ontology analysis [29,30], we found 21
genes among the top 30 abundant genes are enriched in metabolic
Figure 3. Genes and the related biological processes in mouse liver regulated by fasting and refeeding. (A, C) The 8815 selected genes
as described in Materials and Methods and Figure S3A were separated into nine distinct clusters according to the genes upregulated, downregulated
or unaffected by fasting and refeeding compared with normal feeding. Cluster 1 included 83 genes upregulated by fasting and refeeding. Cluster 2
included 50 genes upregulated by fasting and downregulated by refeeding. Cluster 3 included 339 genes upregulated by fasting and unaffected by
refeeding. Cluster 4 included 128 genes downregulated by fasting and upregulated by refeeding. Cluster 5 included 123 genes downregulated by
fasting and refeeding. Cluster 6 included 786 genes downregulated by fasting and unaffected by refeeding. Cluster 7 included 618 genes unaffected
by fasting and upregulated by refeeding. Cluster 8 included 178 genes unaffected by fasting and downregulated by refeeding. Cluster 9 included
6510 genes unaffected by fasting and refeeding. N, gene abundance under normal feeding condition; F, gene abundance under fasting condition; R,
gene abundance under refeeding condition. (B, D) The clustered genes were assigned to different biological processes based on Gene Ontology
using the web tool DAVID. The top biological processes and the case genes in each cluster ranked by P-value were listed (P,0.001, case genes $5).
doi:10.1371/journal.pone.0027553.g003
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27553Figure 4. Network representation of the biological processes in mouse liver regulated by fasting and refeeding. (A) The top 5
connected networks in 1125 genes upregulated or downregulated by fasting and recovered to normal feeding states after refeeding. The gene
networks were analyzed by Ingenuity. Genes upregulated or downregulated by fasting are represented in red or green color respectively. The top 3
networks were shown in (C), (D) and (E). (C) Network of Drug Metabolism, Small Molecule Biochemistry and Endocrine System Development and
Function. (D) Network of Lipid Metabolism, Small Molecule Biochemistry and Molecular Transport. (E) Network of Lipid Metabolism, Molecular
Transport and Small Molecule Biochemistry. (B) The top 5 connected networks of 1180 genes upregulated or downregulated after refeeding
compared to normal feeding. The top 3 networks were shown in (F), (G) and (H). (F) Network of Lipid Metabolism, Small Molecule Biochemistry and
Gene Expression. (G) Network of Lipid Metabolism, Small Molecule Biochemistry and Molecular Transport. (H) Network of Hepatic System Disease,
Lipid Metabolism and Molecular Transport.
doi:10.1371/journal.pone.0027553.g004
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metabolic center. In the top 30 abundant genes, most of them are
well known for their important roles in liver. However the role of a
few genes including Chchd10 and Mettl7a1 in liver is yet to be
elucidated. In the top 30 abundant genes, 18 of them are in the top
30 abundance change genes affected by fasting as shown in
Figure 1. 17 genes among the top 30 abundance change genes
affected by fasting can be enriched in metabolic process. Similarly,
among the top 30 fold change genes affected by fasting, 19 genes
can be clustered in metabolic process. For example, Gck and Pklr
among the 19 genes encoding hexokinase and pyruvate kinase
respectively, are the key genes involved in glycolysis process
[14,31]. It has been reported that the flux through glycolysis
process is attenuated in response to fasting [32]. Consistently, we
found that fasting significantly downregulated Gck and Pklr
(Fig. 1H). In addition, Cyp4a14 and slc16a5, as the top 30 fold
change genes induced by 24-h fasting (Figure 1G), have been
reported to be involved in hypertension and the disposition of
various drugs respectively [33,34,35]. However, the role of
Cyp4a14 and slc16a5 in fasting response is still largely unknown,
and whether Cyp4a14 and slc16a5 are involved in the major
pathways including glucose and lipid metabolism regulated by
fasting needs to be studied in the future. In conclusion, these data
show that the top abundance change and fold change genes
induced by fasting are mainly involved in liver metabolic process.
Further studies focused on these top abundance change or fold
change genes, especially some largely unknown genes, will be very
helpful to understand the gene network and the related
physiological and pathological processes in liver.
It has been shown that hepatic fatty acid, amino acid and
glucose metabolism were altered by fasting [22,23,36,37].
Similarly, we found that fasting significantly affected fatty acid
and amino acid metabolism in liver using Gene Ontology analysis
and KEGG and Ingenuity pathway analysis with the digital gene
expression data from high-throughput sequencing (Figure 2 and
Table 1). In terms of fatty acid metabolism, previous studies show
that fasting induces PPARa, which stimulates the expression of
ACDs and other fatty acid oxidation genes [15,16]. Moreover,
fasting upregulates fatty acid oxidation flux [32,38]. Similarly, our
quantitative data showed that fasting upregulated mRNA levels of
PPARa and Acadm to 1.8- and 3.0-fold respectively. Besides, we
showed fasting-upregulated genes enriched in fatty acid metabo-
lism in Table 1, including Cpt1a, encoding the rate-limiting
enzyme in fatty acid oxidation, and Ehhadh, encoding the key
enzyme catalyzing two steps in fatty acid oxidation [39,40]. In
terms of amino acid metabolism, previous studies showed that
fasting significantly affected genes involved in amino acid
metabolism [37], and increased amino acid feeding into TCA
cycle [32]. Similarly, our data showed that fasting-upregulated
genes are enriched in valine, leucine and isoleucine degradation,
alanine and aspartate metabolism and other amino acids
metabolism (Table 1). It is reported that liver starts to generate
glucose from carbon-3 compounds derived from fatty acid and
amino acid as substrates during fasting [14]. Metabolic fluxes
Figure 5. Genes regulated by fasting or refeeding linked to different liver diseases. (A) The map of top 4 liver diseases enriched with the
genes regulated by fasting. 1509 genes upregulated or downregulated by fasting were assigned to different diseases using the web tool FunDO. The
sizes of the disease nodes are proportional to the number of enriched genes. (B) The number of hit genes and P-value of the top 4 enriched liver
diseases in (A). (C) The map of top 4 liver diseases enriched with the genes upregulated or downregulated after refeeding. 1180 genes affected by
refeeding were assigned to different diseases using the web tool FunDO. (D) The number of hit genes and P-value of the top 4 enriched liver diseases
in (C).
doi:10.1371/journal.pone.0027553.g005
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decreased and limited and absolute gluconeogenesis were
markedly increased in response to fasting [41]. Liver played an
important role in keeping glucose homeostasis mainly through
downregulating glycolytic reactions, upregulating gluconeogenic
reactions and reducing glycogenolysis flux significantly [32,41].
Consistently, our data showed that fasting dramatically downreg-
ulated the mRNA level of pyruvate kinase (Pklr), a key enzyme in
glycolysis [14], to 6.6% (Table S2). Meanwhile fasting upregulated
the mRNA level of PEPCK (Pck1), a key regulatory enzyme in
gluconeogenesis [42], to 3.8-fold. And the mRNA level of glycogen
phosphorylase (Pygl), which catalyzes the rate-limiting step in
glycogenolysis, was downregulated by fasting to 30% (Table S2).
Taken together, our data provide the detailed quantitative gene
expression change involved in the metabolic changes in response
to fasting, such as the reverse of glycolysis to gluconeogenesis,
upregulation of fatty acid and amino acid metabolism for
gluconeogenesis (Figure 2,3, and Table 1). The observed gene
expression changes are in line with previous studies on metabolic
fluxes, and provide new insights into how gene expression is
regulated to meet the metabolic changes in response to fasting. It is
reported that refeeding syndrome is caused by rapid refeeding
after a period of starvation. Refeeding syndrome featured with
hypophosphataemia is caused by rapid refeeding after a period of
starvation, but the underlying molecular mechanism is unclear
[43,44]. Here, we studied the refeeding effect at gene expression
level, and we found that 1180 genes were significantly changed
after refeeding (see Cluster 1, 2, 4, 5, 7 and 8 in Figure 3. and
Table S2). Our results showed that refeeding mainly affected
amino acid, fatty acid and steroid metabolism in liver (Figure 3.
and Table S1), which might provide the underlying molecular
mechanism of refeeding syndrome. As shown in Figure 3, food
availability triggers a dynamic change in metabolic pathways and
is a good model for understanding how these pathways are
mutually organized.
Adult humans often undertake acute fasts for cosmetic, religious
or medical reasons. For example, it has been reported that fasting
was used as a means to control body weight and has long been
advocated as an intermittent treatment for obesity [5]. Hence, the
studies on fasting associated diseases are in great need for human
health. Previous study reported that starvation response in mouse
liver shows strong correlation with life-span-prolonging processes
[22]. Using the web tool FunDO, we found diabetes mellitus, liver
cancer and infection are highly correlated with fasting (Figure 5),
suggesting a molecular connection between fasting and hepatic
diseases. As shown in Table S3, among the 45 genes related to
diabetes mellitus, 17 and 28 genes were upregulated and
downregulated by fasting respectively. Among the 28 downregu-
lated genes, glycogen phosphorylase (Pygl) catalyzes the rate-
limiting step in the degradation of glycogen in animals [14], and
glycogen phosphorylase inhibitors has been proposed as potential
antidiabetic agents [45]. Similarly, thyroid hormone-binding
protein transthyretin (Ttr) downregulated by fasting (Table S3), is
increased in insulin-resistant mice, and lowing thyroid hormone-
binding protein levels may enhance insulin sensitivity in type 2
diabetes [46]. These examples show that the expression changes of
some genes regulated by fasting are beneficial for diabetes.
However, glucokinase (Gck) downregulated by fasting (Table S3),
has been identified as a promising drug target for type 2 diabetes
through its activators [47]. Therefore, fasting induced the
expression change of some genes might leading to the develop-
ment of type 2 diabetes. To further evaluate the effect of fasting on
diabetes mellitus and other diseases, mRNA and protein levels,
and even enzyme activity are required to be combined for detailed
evaluation. Furthermore, other fasting ways, such as long-term
fasting and calorie restriction, need to be used for future studies. In
addition, liver cancer, cirrhosis and diabetes mellitus is highly
correlated with refeeding (Figure 5). Taken together, these results
provide a broad view of genes, food availability and their
correlation with diseases, and whether fasting is good for diseases
treatment needs further studies.
In summary, we have generated a quantitative gene profiling in
feeding, fasting and refeeding mouse liver with high throughput
sequencing. Our results demonstrated food availability induced
dynamic changes of feature biological processes, pathways and
networks. Food availability mainly regulated lipid metabolism,
especially fatty acid metabolism in liver, and is highly correlated
with some liver-related diseases including liver cancer and
diabetes. These quantitative results should be very helpful to
further understand the metabolism and diseases in liver regulated
by food availability.
Materials and Methods
Animal experiments
All animal experimental procedures were approved by the
Institutional Animal Care and Use Committee of the Institute for
Nutritional Sciences (Protocol number 2007-AN-9). C57BL/6
male mice at the age of 7 weeks purchased from SLAC (Shanghai,
China) were randomly divided into three groups for 12 mice per
group, and were allowed to have access to water and diets ad
libitum. At the age of 9 weeks, mice fed ad libitum, fasted for 24 h,
or fasted for 24 h and then refed for 24 h were sacrificed about 3 h
after the beginning of light cycle, and the livers were immediately
removed and snap-frozen in liquid nitrogen.
Sample preparation and solexa library construction
Liver samples were ground in liquid nitrogen, and total RNA
was isolated using Trizol reagent (Invitrogen). The high quality of
total RNA was confirmed by Bioanalyzer 2100 (Agilent). Solexa
libraries were constructed following the manufacturer’s standard
according to the schematic shown in Figure S1.
Solexa sequencing and data analysis
The image files generated by from Illumina 1G sequencer were
processed to produce digital-quality sequence data. Then the high
quality reads were screened from the original data, and the
adaptors were removed from each sequence. Finally, high quality
clean tags were compared with RefSeq database (released at Feb 9,
2009) and the expression level of each gene was normalized to
transcripts per million (TPM). The significance of digital gene
expression profiles were analyzed as described previously [48]. To
avoid the potential noise signal from high-throughput sequencing,
we excluded the genes with average TPM less than 1 in these three
states. The remained 8815 genes were used to calculate the fold
changes and false discovery rate (FDR), which is adjusted p-values
based on ordered p-values for several thousands of genes testing
[49]. In this study, based on the assumption that the majority of
genes are not changed [22], the absolute fold change no less than
1.5 and FDR less than 0.001 were used to define the differentially
expressed genes including the upregulated and downregulated
genes. The genes upregulated, downregulated and unaffected by
fasting were classified into Cluster A, B and C respectively. Cluster
A, B and C were further divided into 9 groups including Cluster 1–
3, 4–6 and 7–9 respectively, according to the upregulated,
downregulated or unaffected effect of refeeding. The expression
pattern of these genes were visualized using the heat-map function
in the R base package [50].
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Gene Ontology constitutes a controlled vocabulary of about
20,000 terms organized in three independent hierarchies for
cellular components, molecular functions, and biological processes
(www.geneontology.org) [51]. The clustered genes were assigned
to biological processes based on Gene Ontology using the web tool
DAVID (http://david.abcc.ncifcrf.gov/home.jsp) [29,30]. Hyper-
geometric test was used as the statistical method to select enriched
biological process Gene Ontology terms for each cluster. The
pathways involved in these gene clusters were analyzed by KEGG
(www.genome.jp/kegg/pathway.html) [52] and Ingenuity (Inge-
nuity Systems Inc.) Network analysis was also performed with
Ingenuity.
FunDo analysis
To study gene-disease relationships, the differentially expressed
genes regulated by fasting or refeeding were assigned to different
diseases based on Disease Ontology and peer-reviewed evidence
from GeneRIF using the web tool FunDO (http://django.nubic.
northwestern.edu/fundo/) [53]. Then Cytoscape v2.6.2 was used
to visualize gene-disease interaction networks [54].
Supporting Information
Figure S1 Schematic of the protocol for constructing the high-
throughput sequencing library from liver total RNA. Magnetic
oligo(dT) beads were used to isolate poly(A) mRNA from the total
RNA samples. cDNA was synthesized from the isolated mRNA
using random hexamer primers. Then the cDNA was digested
with Dpn II, and the standard Solexa protocol for digital gene
expression-tag profiling was followed thereafter to create cDNA
libraries.
(TIF)
Figure S2 Top reads and fold change genes upregulated or
downregulated by refeeding compared to normal feeding. (A) The
top 15 abundance change of genes upregulated or downregulated
by refeeding. (B) The top 15 fold change of genes upregulated or
downregulated by refeeding.
(TIF)
Figure S3 Genes differentially expressed in mouse liver between
feeding, fasting and refeeding states. (A) 8815 genes with average
TPM no less than 1 in the feeding, fasting and refeeding samples
were selected to analyze the gene expression profile. Number of
genes differentially expressed between fasting and feeding states or
between refeeding and feeding states according to the indicated
fold change and FDR value was listed. (B) Venn diagram for the
2305 differentially expressed genes with absolute fold change $1.5
and FDR,0.001. (C) Heat-map images for the 2305 differentially
expressed genes. The selected genes were classified into Cluster 1
to 8, based on the genes upregulated, downregulated, or
unaffected by fasting and/or refeeding. Cluster A and Cluster B
included upregulated and downregulated genes respectively
induced by fasting. Red and blue indicate genes with high and
low abundance respectively.
(TIF)
Table S1 The top 5 Ingenuity and KEGG pathways and the
associated genes significantly affected by fasting and refeeding.
(DOC)
Table S2 Gene expression data of mouse liver under feeding,
fasting and refeeding conditions. The 8815 genes with average
TPM no less than 1 in these three states were listed. N_TPM, the
TPM of the indicated genes under normal feeding condition;
F_TPM, the TPM of the indicated genes under fasting condition;
R_TPM, the TPM of the indicated genes under Refeeding
condition.
(XLS)
Table S3 List of fasting-affected genes enriched in the correlated
liver diseases.
(XLS)
Table S4 List of Refeeding-affected genes enriched in the
correlated liver diseases.
(XLS)
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